David Lagares is an expert in Biochemistry at Massachusetts General Hospital (United States). David Lagares has authored 57 publications, the most recent in 2026. SLR score: 297 (community average: 125). How the SLR is computed.

LeadR Profile

David Lagares Massachusetts General Hospital United States
297 ScienceLeadR Reputation 297
Network Map

Biochemistry

Subspecialties: Internal Medicine - Oncology - Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2010 - 2026

Source: PubMed

Massachusetts General Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 57

Citations

Citations: 4 288 1st author: 11 Last author: 14 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts.
PMID 42127218 — cells, lung, killer cells, natural, fibrosis, immunotherapy, pulmonary fibrosis, fibroblasts, therapeutics
Sci Transl Med20260
Fibroblast-specific palladin drives kidney fibrosis via MRTF-SRF signaling.
PMID 41131992 — kidney diseases, actins, myofibroblasts, fibrosis, diabetic nephropathies, cytoskeleton, pathology, kidney, actin cytoskeleton, fibroblasts, therapeutics
J Pathol20250
Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer.
PMID 40925952 — cells, pancreatic neoplasms, lung, fibrosis, neoplasms, paxillin, cell biology, fibroblasts, therapeutics
Nat Cell Biol20250
Sanglifehrin A mitigates multiorgan fibrosis by targeting the collagen chaperone cyclophilin B.
PMID 38900587 — lung, myofibroblasts, fibrosis, biomedical research, collagen, cyclophilins, fibroblasts, therapeutics, collagen type i
JCI Insight20244
Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors.
PMID 38213031 — glioblastoma, rna, genetic therapy, brain, cells, microscopy, electron, scanning transmission, central nervous system neoplasms, medulloblastoma, 3' untranslated regions, micrornas, oncolytic viruses, zika virus
Mol Ther20247

LeadR Networks

Main global connection map